Registro:

Referencias:

• Castaño, E.M., Frangione, B., Biology of disease: Human amyloidosis, Alzheimer's disease and related disorders (1988) Lab. Invest., 58, pp. 122-132
• Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., St. George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Roses, A.D., Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease (1993) Neurology, 43, pp. 1467-1472
• Kovacs, D.M., α2-macroglobulin in late-onset Alzheimer's disease (2000) Exp. Gerontol., 35, pp. 473-479
• Bertram, L., Blacker, D., Mullin, K., Keeney, D., Jones, J., Basu, S., Yhu, S., Tanzi, R.E., Evidence for genetic linkage of Alzheimer's disease to chromosome 10q (2000) Science, 290, pp. 2302-2303
• Ertekin-Taner, N., Graff-Radford, N., Younkin, L.H., Eckman, C., Baker, M., Adamson, J., Ronald, J., Younkin, S.G., Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees (2000) Science, 290, pp. 2303-2304
• Myers, A., Holmans, P., Marshall, H., Kwon, J., Meyer, D., Ramic, D., Shears, S., Goate, A.M., Susceptibility locus for Alzheimer's disease on chromosome 10 (2000) Science, 290, pp. 2304-2305
• Perez, A., Morelli, L., Cresto, J.C., Castaño, E.M., Degradation of soluble amyloid β-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains (2000) Neurochem. Res., 25, pp. 247-255
• Castaño, E.M., Prelli, F., Wisniewski, T., Golabek, A., Kumar, R.A., Soto, C., Frangione, B., Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E (1995) Biochem. J., 306, pp. 599-604
• Bullido, M.J., Guallar-Castillon, P., Artiga, M.J., Ramos, M.C., Sastre, I., Aldudo, J., Frank, A., Valdivieso, F., Alzheimer's risk associated with human apolipoprotein E, α2 macroglobulin and lipoprotein receptor related protein polymorphisms: Absence of genetic interactions, and modulation by gender (2000) Neurosci. Lett., 289, pp. 213-216
• Hu, J., Miyatake, F., Aizu, Y., Nakagawa, H., Nakamura, S., Tamaoka, A., Takahash, R., Shoji, M., Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population (1999) Neurosci. Lett., 277, pp. 65-67
• Narain, Y., Yip, A., Murphy, T., Brayne, C., Easton, D., Evans, J.G., Xuereb, J., Rubinsztein, D.C., The ACE gene and Alzheimer's disease susceptibility (2000) J. Med. Genet., 37, pp. 695-697
• Crawford, F.C., Freeman, M.J., Schinka, J.A., Abdullah, L.I., Gold, M., Hartman, R., Krivian, K., Mullan, M.J., A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease (2000) Neurology, 55, pp. 763-768
• Finckh, U., Von der Kammer, H., Velden, J., Michel, T., Andresen, B., Deng, A., Zhang, J., Nitsch, R.M., Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease (2000) Arch. Neurol., 57, pp. 1579-1583
• Greenberg, S.M., Briggs, M.E., Hyman, B.T., Kokoris, G.J., Takis, C., Kanter, D.S., Kase, C.S., Pessin, M.S., Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy (1996) Stroke, 27, pp. 1333-1337
• Verbeek, M.M., Van Nostrand, W.E., Otte-Holler, I., Wesseling, P., De Waal, R.M., Amyloid-β-induced degeneration of human brain pericytes is dependent on the apolipoprotein E genotype (2000) Ann. N. Y. Acad. Sci., 903, pp. 187-199
• Jordan, B.D., Kanik, A.B., Horwich, M.S., Sweeney, D., Relkin, N.R., Petito, C.K., Gandy, S., Apolipoprotein E epsilon 4 and fatal cerebral amyloid angiopathy associated with dementia pugilistica (1995) Ann. Neurol., 38, pp. 698-699
• Graham, D.I., Gentleman, S.M., Nicoll, J.A., Royston, M.C., McKenzie, J.E., Roberts, G.W., Griffin, W.S., Altered βAPP metabolism after head injury and its relationship to the aetiology of Alzheimer's disease (1996) Acta Neurochir. Suppl. (Wien), 66, pp. 96-102
• Tokuda, T., Fukushima, T., Ikeda, S., Sekijima, Y., Shoji, S., Yanagisawa, N., Tamaoka, A., Plasma levels of amyloid β proteins Aβ1-40 and Aβ1-42(43) are elevated in Down's syndrome (1997) Ann. Neurol., 41, pp. 271-273
• Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Selkoe, D.J., Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice (1997) Nature Med., 3, pp. 67-72
• Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T.D., Younkin, S., Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease (1996) Nature Med., 2, pp. 864-870
• Peacock, M.L., Murman, D.L., Sima, A.A., Warren J.T., Jr., Roses, A.D., Fink, J.K., Novel amyloid precursor protein gene mutation (codon 665 Asp) in a patient with lateonset Alzheimer's disease (1994) Ann. Neurol., 35, pp. 432-438
• Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A.Y., Seubert, P., Vigo-Pelfrey, C., Selkoe, D.J., Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production (1992) Nature, 360, pp. 672-674
• Carter, D.A., Desmarais, E., Bellis, M., Campion, D., Clerget-Darpoux, F., Brice, A., Agid, Y., Mallet, J., More missense in amyloid gene (1992) Nature Genet., 2, pp. 255-256
• Maruyama, K., Tomita, T., Shinozaki, K., Kume, H., Asada, H., Saido, T.C., Ishiura, S., Obata, K., Familial Alzheimer's disease-linked mutations at Va1717 of amyloid precursor protein are specific for the increased secretion of Aβ42(43) (1996) Biochem. Biophys. Res. Commun., 227, pp. 730-735
• Kwok, J.B., Li, Q.X., Hallupp, M., Whyte, S., Ames, D., Beyreuther, K., Masters, C.L., Schofield, P.R., Novel Leu723Pro amyloid precursor protein mutation increases amyloid β42(43) peptide levels and induces apoptosis (2000) Ann. Neurol., 47, pp. 249-253
• Peacock, M.L., Warren J.T., Jr., Roses, A.D., Fink, J.K., Novel polymorphism in the A4 region of the amyloid precursor protein gene in a patient without Alzheimer's disease (1993) Neurology, 43, pp. 1254-1256
• Wisniewski, T., Ghiso, J., Frangione, B., Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation (1991) Biochem. Biophys. Res. Commun., 173, pp. 1247-1254
• Miravalle, L., Tokuda, T., Chiarle, R., Giaccone, G., Bugiani, O., Tagliavini, F., Frangione, B., Ghiso, J., Substitutions at codon 22 of Alzheimer's Aβ peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells (2000) J. Biol. Chem., 275, pp. 27110-27116
• Walsh, D.M., Hartley, D.M., Condron, M.M., Selkoe, D.J., Teplow, D.B., In vitro studies of amyloid β-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692→Gly) Alzheimer's disease (2001) Biochem. J., 355, pp. 869-877
• De Jonghe, C., Zehr, C., Yager, D., Prada, C.M., Younkin, S., Hendriks, L., Van Broeckhoven, C., Eckman, C.B., Flemish and Dutch mutations in amyloid β precursor protein have different effects on amyloid β secretion (1998) Neurobiol. Dis., 5, pp. 281-286
• Hamazaki, H., Aβ-amyloid peptide variant related with familial Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis is poorly eliminated by cathepsin D (1996) FEBS Lett., 397, pp. 313-315
• Nilsberth, C., Westlind-Danielsson, A., Eckman, C.B., Condron, M.M., Axelman, K., Forsell, C., Stenh, C., Lannfelt, L., The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation (2001) Nature Neurosci., 4, pp. 887-893
• Van Nostrand, W.E., Melchor, J.P., Cho, H.S., Greenberg, S.M., Rebeck, G.W., Pathogenic effects of D23N Iowa mutant amyloid β-protein (2001) J. Biol. Chem., 276, pp. 32860-32866
• Coria, F., Castaño, E.M., Frangione, B., Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease β-protein (1987) Am. J. Pathol., 129, pp. 422-428
• Glenner, G.G., Wong, C.W., Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein (1984) Biochem. Biophys. Res. Commun., 122, pp. 1131-1135
• Kang, J., Lemaire, H.G., Unterbeck, A., Salbaum, J.M., Masters, C.L., Grzeschik, K.H., Multhaup, G., Muller-Hill, B., The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor (1987) Nature, 325, pp. 733-736
• Esler, W.P., Wolfe, M.S., A portrait of Alzheimer secretases - New features and familiar faces (2001) Science, 293, pp. 1449-1454
• Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L., Beyreuther, K., Amyloid plaque core protein in Alzheimer's disease and Down syndrome (1995) Proc. Natl. Acad. Sci. USA, 82, pp. 4245-4249
• Miller, D.L., Papayannopoulos, I.A., Styles, J., Bobin, S.A., Lin, Y.Y., Biemann, K., Iqbal, K., Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease (1993) Arch. Biochem. Biophys., 301, pp. 41-52
• Jarrett, J.T., Lansbury P.T., Jr., Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? (1993) Cell, 73, pp. 1055-1058
• Harkany, T., Abraham, I., Konya, C., Nyakasc, C., Zarandi, M., Penke, B., Luiten, P.G., Mechanisms of β-amyloid neurotoxicity: Perspectives of pharmacotherapy (2000) Rev. Neurosci., 11, pp. 329-332
• Castaño, E.M., Prelli, F., Soto, C., Beavis, R., Matsubara, E., Shoji, M., Frangione, B., The length of amyloid β in hereditary cerebral hemorrhage with amyloidosis, Dutch type (1996) J. Biol. Chem., 271, pp. 32185-32191
• Davis, J., Van Nostrand, W.E., Enhanced pathologic properties of Dutch-type mutant amyloid β-protein (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 2996-3000
• Kojro, E., Gimpl, G., Lammich, S., Marz, W., Fahrenholz, F., Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10 (2001) Proc. Natl. Acad. Sci. USA, 98, pp. 5815-5820
• Zhu, G., Wang, D., Lin, Y.H., McMahon, T., Koo, E.H., Messing, R.O., Protein kinase C epsilon suppresses Aβ production and promotes activation of α-secretase (2001) Biochem. Biophys. Res. Commun., 285, pp. 997-1006
• Xu, H., Gouras, G.K., Greenfield, J.P., Vincent, B., Naslund, J., Mazzarelli, L., Fried, G., Gandy, S., Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides (1998) Nature Med., 4, pp. 447-451
• Zhang, L., Song, L., Parker, E.M., Calpain inhibitor 1 increases β-amyloid peptide production by inhibiting the degradation of the substrate of β-secretase. Evidence that substrate availability limits β-amyloid peptide production (1999) J. Biol. Chem., 274, pp. 8966-8972
• Turner, A.J., Tanzawa, K., Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX (1997) FASEB J., 11, pp. 355-364
• Turner, A.J., Isaac, R.E., Coates, D., The neprilysin (NEP) family of zinc metalloendopeptidases: Genomics and function (2001) BioEssays, 23, pp. 261-269
• Schwartz, J.C., De La Baume, S., Malfroy, B., Patey, G., Perdrisot, R., Swerts, J.P., Foumie-Zaluski, M.C., Roques, B.P., "Enkephalinase", a newly characterized dipeptidyl carboxypeptidase: Properties and possible role in enkephalinergic transmission (1980) Intl. J. Neurol., 14, pp. 195-204
• Sato, M., Ikeda, K., Haga, S., Allsop, D., Ishii, T., A monoclonal antibody to common acute lymphoblastic leukemia antigen immunostains senile plaques in the brains of patients with Alzheimer' disease (1991) Neurosci. Lett., 121, pp. 271-273
• Howell, S., Nalbantoglu, J., Crine, P., Neutral endopeptidase can hydrolyze β-amyloid (1-40) but shows no effect on β-amyloid precursor protein metabolism (1995) Peptides, 16, pp. 647-652
• Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Saido, T.C., Identification of the major Aβ (1-42) degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition (2000) Nature Med., 6, pp. 143-150
• Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N.P., Gerard, C., Saido, T.C., Metabolic regulation of brain Aβ by neprilysin (2001) Science, 292, pp. 1550-1552
• Yasojima, K., Haruhiko, A., McGeer, E.G., McGeer, P.L., Reduced neprilysin in high plaque areas of Alzheimer brain: A possible relationship to deficient degradation of β amyloid peptide (2001) Neurosci. Lett., 297, pp. 97-100
• Eckman, E.A., Reed, D.K., Eckman, C.B., Degradation of the Alzheimer's amyloid β peptide by endothelinconverting enzyme (2001) J. Biol. Chem., 276, pp. 24540-24548
• Hu, J., Igarashi, A., Kamata, M., Nakagawa, H., Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ), retards Aβ aggregation, deposition, fibril formation and inhibits cytotoxicity (2001) J. Biol. Chem., 276, pp. 47863-47868
• Becker, A.B., Roth, R.A., An unusual active site identified in a family of zinc metallopeptidases (1992) Proc. Natl. Acad. Sci. (USA), 89, pp. 3835-3839
• Hooper, N.M., Families of zinc metalloproteases (1994) FEBS Lett., 354, pp. 1-6
• Qiu, W.Q., Walsh, D.M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M.B., Rosner, M.R., Selkoe, D.J., Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation (1998) J. Biol. Chem., 273, pp. 32730-32738
• Baumeister, H., Müller, D., Rehbein, M., Richter, D., The rat insulin-degrading enzyme. Molecular cloning and characterization of tissue-specific transcripts (1993) FEBS Lett., 317, pp. 250-254
• Kuo, W., Montag, A.G., Rosner, M.R., Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues (1993) Endocrinology, 132, pp. 604-611
• Authier, F., Posner, B.I., Bergeron, J.J.M., Insulin degrading enzyme (1996) Clin. Invest. Med., 19, pp. 149-158
• Kurochkin, I.V., Insulin-degrading enzyme: Embarking on amyloid destruction (2001) Trends Biochem. Sci., 26, pp. 421-425
• Kurochkin, I.V., Amyloidogenic determinants as a substrate recognition motif of insulin-degrading enzyme (1998) FEBS Lett., 427, pp. 153-156
• Kurochkin, I.V., Goto, S., Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme (1994) FEBS Lett., 345, pp. 33-37
• McDermott, J.R., Gibson, A.M., Degradation of Alzheimer's β-amyloid protein by human and rat peptidases: Involvement of insulin-degrading enzyme (1997) Neurochem. Res., 22, pp. 49-56
• Vekrellis, K., Zhen, Ye., Qiu, W.Q., Walsh, D., Hartley, D., Chesneau, V., Rosner, M.R., Selkoe, D.J., Neurons regulate extracellular levels of amyloid β-protein via proteolysis by insulin-degrading enzyme (2000) J. Neurosci., 20, pp. 1657-1665
• Sudoh, S., Frosch, M.P., Wolf, B.A., Differential effects of proteases involved in intracellular degradation of amyloid β-protein between detergent-soluble and -insoluble pools in CHO-695 cells (2002) Biochemistry, 41, pp. 1091-1099
• Gasparini, L., Gouras, G.K., Wang, R., Gross, R.S., Flint Beal, M., Greengard, P., Xu, H., Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated protein kinase signaling (2001) J. Neurosci., 21, pp. 2561-2570
• Mukherjee, A., Song, E., Kihiko-Ehmann, M., Goodman, J.P., St. Pyrek, J., Estus, E., Hersh, L.B., Insulysin hydrolyzes amyloid β peptides to products that are neither neurotoxic nor deposit on amyloid plaques (2000) J. Neurosci., 20, pp. 8745-8749
• Abraham, R., Myers, A., Wavrant-DeVrieze, F., Hamshere, M.L., Thomas, H.V., Marshall, H., Compton, D., Jones, L., Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease (2001) Hum. Genet., 109, pp. 646-652
• Reuning, U., Magdolen, V., Wilhelm, O., Fischer, K., Lutz, V., Graeff, H., Schmitt, M., Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (1998) Int. J. Oncol., 13, pp. 893-906
• Lijnen, H.R., Elements of the fibrinolytic system (2001) Ann. N.Y. Acad. Sci., 936, pp. 226-236
• Chen, Z.L., Strickland, S., Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin (1997) Cell, 91, pp. 917-925
• Stern, R.A., Trojanowski, J.Q., Lee, V.M., Antibodies to the β-amyloid peptide cross react with conformational epitopes in human subunits from peripheral blood (1990) FEBS Lett., 264, pp. 43-47
• Kingston, I.B., Castro, M.J., Anderson, S., In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid β-peptide analogues (1995) Nature Med., 1, pp. 138-142
• Van Nostrand, W., Porter, M., Plasmin cleavage of the amyloid β protein alteration of secondary structure and stimulation of tissue plasminogen activator activity (1999) Biochemistry, 38, pp. 11570-11576
• Tucker, H.M., Kihiko, M., Caldwell, J.N., Wright, S., Kawarabayashi, T., Price, D., Walker, D., Estus, S., The plasmin system is induced by and degrades amyloid β aggregates (2000) J. Neurosci., 20, pp. 3937-3946
• Sutton, R., Keohane, M.E., Van der Berg, S.R., Gonias, S.L., Plasminogen activator inhibitor-1 in the cerebrospinal fluid as an index of neurological disease (1994) Blood Coagul. Fibrinolysis, 5, pp. 167-171
• Ledesma, M.D., Da Silva, J.S., Crassaerts, K., Delacourte, A., De Strooper, B., Dotti, C.G., Brain plasmin enhances APP α-cleavage and Aβ degradation and is reduced in Alzheimer's disease brains (2000) EMBO Reports, 1, pp. 530-535
• Qiu, W.Q., Borth, W., Ye, Z., Haass, C., Teplow, D.B., Selkoe, D.J., Degradation of amyloid beta-protein by a serine protease-α2-macroglobulin complex (1996) J. Biol. Chem., 271, pp. 8443-8451
• Yamin, R., Malgeri, E.G., Sloane, J.A., McGraw, W.T., Abraham, C.R., Metalloendopeptidase EC 3.4.24.15 is necessary for Alzheimer's amyloid-β peptide degradation (1999) J. Biol. Chem., 274, pp. 18777-18784
• Abraham, C.R., Selkoe, D.J., Potter, H., Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease (1988) Cell, 52, pp. 487-501
• Ma, J., Yee, A., Brewer H.B., Jr., Das, S., Potter, H., Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments (1994) Nature, 372, pp. 92-94
• Waters, S.M., Davis, T.P., Alterations of peptide metabolism and neuropeptidase activity in senile dementia of the Alzheimer's type (1995) Ann. N.Y. Acad. Sci., 814, pp. 30-39
• Yong, V.W., Krekowski, C.A., Forsyth, P.A., Bell, R., Edwards, D.R., Matrix metalloproteinases and diseases of the CNS (1998) Trends Neurosci., 21, pp. 75-80
• Brew, K., Dinakarpandian, D., Nagase, H., Tissue inhibitors of metalloproteinases: Evolution, structure and function (2000) Biochim. Biophys. Acta, 1477, pp. 267-283
• Peress, N., Perillo, E., Zucker, S., Localization of tissue inhibitor of matrix metalloproteinases in Alzheimer's disease and normal brain (1995) J. Neuropathol. Exp. Neurol., 54, pp. 16-22
• Backstrom, J.R., Lim, G.P., Cullen, M.J., Tokes, Z.A., Matrix metalloproteinase 9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degradaing the amyloid β peptide (1-40) (1996) J. Neurosci., 16, pp. 7910-7919
• Strongin, A.Y., Collier, I., Bannikov, G., Marmer, B.L., Grant, G.A., Goldberg, G.I., Mechanism of cell surface activation of 72 kDa type IV collagenase (1995) J. Biol. Chem., 270, pp. 5331-5338
• Roher, A.E., Kasunic, T.C., Woods, A.S., Cotter, R.J., Ball, M.J., Fridman, R., Proteolysis of Aβ peptide from Alzheimer's disease brain by gelatinase A (1994) Biochem. Biophys. Res. Commun., 205, pp. 1755-1761
• Deb, S., Gottschall, P.E., Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with β-amyloid peptides (1996) J. Neurochem., 66, pp. 1641-1647
• Deb, S., Zhang, J.W., Gottschall, P.E., Activated isoforms of MMP-2 are induced in U87 human glioma cells in response to β-amyloid peptide (1999) J. Neurosci. Res., 55, pp. 44-53
• Morelli, L., Prat, M.I., Castaño, E.M., Differential accumulation of soluble amyloid β peptides 1-40 and 1-42 in human monocytic and neuroblastoma cell lines: Implications for cerebral amyloidogenesis (1999) Cell & Tissue Res., 298, pp. 225-232
• Boland, K., Behrens, M., Choi, D., Manias, K., Perlmutter, D.H., The serpin-enzyme complex receptor recognizes soluble, non-toxic amyloid β peptide but not aggregated cytotoxic amyloid β peptide (1996) J. Biol. Chem., 271, pp. 18032-18044
• Narita, M., Holtzman, D.M., Schwartz, A.L., Bu, G., α2-macroglobulin complexes with and mediates the endocytosis of β-amyloid peptide via cell surface low-density lipoprotein receptor-related protein (1997) J. Neurochem., 69, pp. 1904-1911
• Paresce, D.M., Ghosh, R.N., Maxfield, F.R., Microglial cells internalize aggregates of the Alzheimer's disease amyloid β protein via a scavenger receptor (1996) Neuron, 17, pp. 553-565
• Strickland, D.K., Kounnas, M.Z., Argraves, W.S., LDL receptor-related protein: A multiligand receptor for lipoprotein and proteinase catabolism (1995) FASEB J., 9, pp. 890-898
• Kang, D.E., Pietrzik, C.U., Baum, L., Chevallier, N., Merriam, D.E., Kounnas, M.Z., Wagner, S.L., Koo, E.H., Modulation of amyloid β clearence and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway (2000) J. Clin. Invest., 106, pp. 1159-1166
• Van Uden, E., Carlson, G., St. George Hyslop, P., Westaway, D., Orlando, R., Mallory, M., Rockenstein, E., Masliah, E., Aberrant presenilin-1 expression downregulates LDL receptor-related protein (LRP): Is LRP central to Alzheimer's disease pathogenesis? (1999) Mol. Cell Neurosci., 14, pp. 129-140
• Bu, G., Maksymovitch, E.A., Nerbonne, J.M., Schwartz, A.L., Expression and function of the low density lipoprotein receptor related protein (LRP) in mammalian central neurons (1994) J. Biol. Chem., 269, pp. 18521-18528
• Hammad, S.M., Ranganathan, S., Loukinova, E., Twai, W.O., Argraves, W.S., Interaction of apolipoprotein Jamyloid β peptide complex with low density lipoprotein receptor-related protein -2/megalin. A mechanism to prevent pathological accumulation of amyloid β peptide (1997) J. Biol. Chem., 272, pp. 18644-18649
• Hamazaki, H., Cathepsin D is involved in the clearence of Alzheimer's β-amyloid protein (1996) FEBS Lett., 396, pp. 139-142
• McDermott, J.R., Gibson, A.M., Degradation of Alzheimer's β-amyloid protein by human cathepsin D (1996) Neuroreport, 7, pp. 2163-2166
• Gupta-Bansal, R., Frederickson, R.C., Brunden, K.R., Proteoglycan-mediated inhibition of Aβ proteolysis: A potential cause of senile plaque accumulation (1995) J. Biol. Chem., 270, pp. 18666-18671
• Liuzzo, J.P., Petanceska, S.S., Devi, L.A., Neurotrophic factors regulate cathepsin S in macrophages and microglia: A role in the degradation of myelin basic protein and amyloid β peptide (1999) Mol. Med., 5, pp. 334-343
• Frautschy, S.A., Horn, D.L., Sigel, J.J., Harris-White, M.E., Mendoza, J.J., Yang, F., Saido, T.C., Cole, G.M., Protease inhibitor coinfusion with amyloid β-protein results in enhanced deposition and toxicity in rat brain (1998) J. Neurosci., 18, pp. 8311-8321
• Ii, K., Ito, H., Kominami, E., Hirano, A., Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonimdementia complex on Guam and senile dementia and in the aged (1993) Virchows Arch., 423, pp. 185-194
• Cataldo, A.M., Hamilton, D.J., Nixon, R.A., Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease (1994) Brain Res., 640, pp. 68-80
• Wiederanders, B., Oelke, B., Accumulation of inactive cathepsin D in old rats (1984) Mech. Ageing Dev., 24, pp. 265-271
• Matus, A., Green, D.J., Age-related increase in a cathepsin D like protease that degrades brain microtubule-associated protein (1987) Biochemistry, 26, pp. 8083-8086
• Kenessey, A., Banay-Schwartz, M., De Guzman, T., Lajtha, A., Increase in cathepsin D activity in rat brain in aging (1989) J. Neurosci. Res., 23, pp. 454-456
• Cataldo, A.M., Barnett, J.L., Berman, S.A., Li, J., Quarless, S., Bursztajn, S., Lippa, C., Nixon, R.A., Gene expression and cellular content of cathepsin D in human neocortex: Evidence for early upregulation of the endosomal-lysosomal system in pyramidal neurons in Alzheimer disease (1995) Neuron, 14, pp. 1-20
• Hoffman, K.B., Bi, X., Pham, J.T., Lynch, G., β amyloid increases cathepsin D levels in hippocampus (1998) Neurosci. Lett., 250, pp. 75-78
• Papassotiropoulos, A., Bagli, M., Feder, O., Jessen, F., Maier, W., Rao, M.L., Ludwig, M., Heun, R., Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease (1999) Neurosci. Lett., 262, pp. 171-174
• Nishimura, K., Hazato, T., Isolation and identification of an endogenous inhibitor of enkephalin-degrading enzymes from bovine spinal cord (1993) Biochem. Biophys. Res. Commun., 194, pp. 713-719
• McKenzie, R.A., Burghen, G.A., Partial purification and characterization of insulin protease and its intracellular inhibitor from rat liver (1984) Arch. Biochem. Biophys., 229, pp. 604-611
• Ogawa, W., Shii, K., Yonezawa, K., Baba, S., Yokono, K., Affinity purification of insulin-degrading enzyme and its endogenous inhibitor from rat liver (1992) J. Biol. Chem., 267, pp. 1310-1316
• Ponte, P., Gonzalez-De Whitt, P., Schilling, J., Miller, J., Hsu, D., Greenberg, B., Davis, K., Fuller, F., A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors (1988) Nature, 331, pp. 525-527
• Tanzi, R.E., McClatchey, A.I., Lampert, E.D., Villa-Komaroff, L., Gusella, J.F., Neve, R.L., Protease inhibitor domain encoded by an amyloid protein precursor (1988) Nature, 331, pp. 528-530
• Miyazaki, K., Hasegawa, M., Funahashi, K., Umeda, M., A metalloprotease inhibitor domain in Alzheimer amyloid protein precursor (1993) Nature, 362, pp. 839-841
• Mucke, L., Yu, G.-Q., McColongue, L., Rockenstein, E.M., Abraham, C.R., Masliah, E., Astroglial expression of human α1-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice (2000) Am. J. Pathol., 157, pp. 2003-2010
• Nilsson, L.N.G., Bales, K.R., DiCarlo, G., Gordon, M.N., Morgan, D., Paul, S.M., Potter, H., α1-antichymotrypsin promotes β-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease (2001) J. Neurosci., 21, pp. 1444-1451
• Nilsson, L.N., Das, S., Potter, H., Effect of cytokines, dexamethazone and the A/T-signal peptide polymorphism on the expression of α1-antichymotrypsin in astrocytes: Significance for Alzheimer's disease (2001) Neurochem. Int., 39, pp. 361-370
• Haan, J., Maat-Schieman, M.L., Van Duinen, S.G., Jensson, O., Thorsteinsson, L., Roos, R.A., Co-localization of β/A4 and cystatin C in cortical blood vessels in Dutch, but not in Icelandic hereditary cerebral hemorrhage with amyloidosis (1994) Acta Neurol. Scand., 89, pp. 367-371
• Levy, E., Sastre, M., Kumar, A., Gallo, G., Piccardo, P., Ghetti, B., Tagliavini, F., Codeposition of cystatin C with amyloid β protein in the brain of Alzheimer disease patients (2001) J. Neuropathol. Exp. Neurol., 60, pp. 94-104
• Deng, A., Irizarry, M.C., Nitsch, R.M., Growdon, J.H., Robeck, G.W., Elevation of cystatin C in susceptible neurons in Alzheimer's disease (2001) Am. J. Pathol., 159, pp. 1061-1068
• Li, C., Hersh, L.B., Characterization of the promoter region of the rat neprilysin gene (1998) Arch. Biochem. Biophys., 358, pp. 189-195
• Li, C., Chen, G., Gerard, N.P., Gerard, C., Bozic, C.R., Hersh, L.B., Comparison of the structure and expression of the human and rat neprilysin (endopeptidase 24.11)-encoding genes (1995) Gene, 164, pp. 363-366
• Shen, R., Sumitomo, M., Dai, J., Hardy, D.O., Navarro, D., Usmani, B., Papandreou, C.N., Nanus, D.M., Identification and characterization of two androgen response regions in the human neutral endopeptidase gene (2000) Mol. Cell Endocrinol., 170, pp. 131-142
• Melino, G., Draoui, M., Bernardini, S., Bellincampi, L., Reichert, U., Cohen, P., Regulation by retinoic acid of insulin-degrading enzyme and of a related endoprotease in human neuroblastoma cell lines (1996) Cell Growth Diff., 7, pp. 787-796
• Webster, S.D., Galvan, M.D., Ferran, E., Garzon-Rodriguez, W., Glabe, C.G., Tenner, A.J., Antibody-mediated phagocytosis of the amyloid β-peptide in microglia is differentially modulated by C1q (2001) J. Immunol., 166, pp. 7496-7503
• Poduslo, J.F., Whelan, S.L., Curran, G.L., Wengenack, T.M., Therapeutic benefit of polyamine-modified catalase as a scavenger of hydrogen peroxide and nitric oxide in familial amyotrophic lateral sclerosis transgenics (2000) Ann. Neurol., 48, pp. 943-947
• Bickel, U., Yoshikawa, T., Pardridge, W.M., Delivery of peptides and proteins through the blood-brain barrier (2001) Adv. Drug Deliv. Rev., 46, pp. 247-249
• Aebischer, P., Ridet, J.L., Recombinant proteins for neurodegenerative diseases: The delivery issue (2001) Trends Neurosci., 24, pp. 533-540
• Kordower, J.H., Emborg, M.E., Bloch, J., Ma, S.Y., Chu, Y., Leventhal, L., McBride, J., Aebischer, P., Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease (2000) Science, 290, pp. 767-773
• Corti, O., Sanchez-Capelo, A., Colin, P., Hanoun, N., Hamon, M., Mallet, J., Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirusmediated gene transfer to a rat model of Parkinson's disease (1999) Proc. Natl. Acad. Sci. (USA), 96, pp. 12120-12125
• Xu, H., Sweeney, D., Wang, R., Thinakaran, G., Lo, A.C., Sisodia, S.S., Greengard, P., Gandy, S., Generation of Alzheimer β-amyloid protein in the trans-Golgi network in the apparent abscence of vesicle formation (1997) Proc. Acad. Natl. Sci. USA, 94, pp. 3748-3752
• Zhang, Y., Mc Laughlin, R., Goodyer, C., Le Blanc, A., Selective cytotoxicity of intracellular amyloid β peptide 1-42 through p53 and Bax in cultured primary human neurons (2002) J. Cell Biology, 156, pp. 519-529
• Tomiyama, T., Asano, S., Furiya, Y., Shirasawa, T., Endo, N., Mori, H., Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid β protein analogues (1994) J. Biol. Chem., 269, pp. 10205-10208
• Shapira, R., Austin, G.E., Mirra, S.S., Neuritic plaque amyloid in Alzheimer's disease is highly racemized (1988) J. Neurochem., 50, pp. 69-74
• Kuo, Y.M., Kokjohn, T.A., Beach, T.G., Sue, L.I., Brune, D., Lopez, J.C., Kalback, W.M., Roher, A.E., Comparative analysis of amyloid-β chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains (2001) J. Biol. Chem., 276, pp. 12991-12998
• Wijdicks, E.F., Jack C.R., Jr., Intracerebral hemorrhage after fibrinolytic therapy for acute myocardial infarction (1993) Stroke, 24, pp. 554-557

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------